Top
Note: You're navigating the results of models obtained with the previous release of IntOGen (2020). A new boostDM version corresponding to the current IntOGen release will be available soon.
CDKN2A 9:21971196:G (G55R) × HC ×
Driver potential information
Model BoostDM class BoostDM score
(HC) Hepatic cancer Passenger 0.46
Feature importance

Place the mouse pointer over a mutational feature for additional information. See the FAQs for more details about the feature importance.

Feature Feature value SHAP value
Linear Clustering Score (LCS) 0.00 -0.13 Medium negative
Linear Clustering in Cancer Type (LCT) 0.00 -0.07 Non-significant
Linear Clustering (LC) 0.00 0.04 Non-significant
3D Clustering in Cancer Type (3CT) 0.00 -0.24 Medium negative
3D clustering (3C) 0.00 -0.25 Medium negative
Recurrent in PFAM Domain (DOM) 0.00 0.00 Non-significant
Recurrent in PFAM Domain v2 (DOM2) 0.00 0.00 Non-significant
PhyloP 100-way Score (PHYLOP) 7.31 0.91 Medium positive
Stop Codon in Last Exon (NMD) 0.00 0.00 Non-significant
Post-translational Modification Site: Acetylation (ACETYLATION) 0.00 0.00 Non-significant
Post-translational Modification Site: Methylation (METHYLATION) 0.00 0.00 Non-significant
Post-translational Modification Site: Phosphorylation (PHOS) 0.00 0.00 Non-significant
Post-translational Modification Site: Regulatory site (REG) 0.00 0.00 Non-significant
Post-translational Modification Site: Ubiquitination (UB) 0.00 0.00 Non-significant
Consequence Type: Missense (MISSENSE) 1.00 0.38 Medium positive
Consequence Type: Nonsense (NONSENSE) 0.00 -0.50 Medium negative
Consequence Type: Splice-affecting (SPLICE) 0.00 -0.21 Medium negative
Consequence Type: Synonymous (SYNONYMOUS) 0.00 0.00 Non-significant